menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Glycemic Control and Macrovascular Outcomes in Patients with Diabetes Using the Archimedes Model

close
Glycemic Control and Macrovascular Outcomes in Patients with Diabetes Using the Archimedes Model
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    The assessment of intensive glycemic control in preventing cardiovascular disease is unclear. Discrepancies in recent clinical trials such as ACCORD, ADVANCE, PROactive and UKPDS 80 may reflect difference in study design and patients, versus glycemic control. How can using the Archimedes model illuminate this quandary? Join host Dr. Steven Edelman and his guest, chief scientific and medical officer of the American Diabetes Association, Dr. David Kendall, as they discuss the effect of glycemic control on macrovascular outcomes in patients with diabetes.

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The assessment of intensive glycemic control in preventing cardiovascular disease is unclear. Discrepancies in recent clinical trials such as ACCORD, ADVANCE, PROactive and UKPDS 80 may reflect difference in study design and patients, versus glycemic control. How can using the Archimedes model illuminate this quandary? Join host Dr. Steven Edelman and his guest, chief scientific and medical officer of the American Diabetes Association, Dr. David Kendall, as they discuss the effect of glycemic control on macrovascular outcomes in patients with diabetes.

     

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 7/6/20